Pfizer and BioNTech to provide 500 million Doses to U.S Government

BioNTech and Pfizer has announced its plans to provide 500 million doses to U.S government at a non profit price.

Approximately around 200 million doses in 2021 and 300 million by the first half of 2022. These doses from Pfizer and BioNTech will be donated to low and lower middle income countries including the African Union.

The Government of U.S will work with COVAX to ensure these vaccines are delivered to the relevant countries.

The Chairman and Chief Executive Officer of Pfizer, Albert Bourla, said:

“Our partnership with the U.S. government will help bring hundreds of millions of doses of our vaccine to the poorest countries around the world as quickly as possible.

“COVID-19 has impacted everyone, everywhere, and to win the battle against this pandemic, we must ensure expedited access to vaccines for all.

“I want to thank President Biden for his leadership in protecting the least advantaged of our global neighbors,”

“Fair and equitable distribution has been our North Star since Day One and we are proud to do our part to help vaccinate the world, a massive but an achievable undertaking.”

The M.D., CEO and Co-Founder of BioNTech, Ugur Sahin, said:

“As a vaccine developer, we felt the duty to develop a well-tolerated and highly effective vaccine and make it available to as many people worldwide as possible.

Today’s agreement underlines that the joint efforts of the private and the public sector are providing solutions to help end this pandemic,”.

“We are also committed to realizing sustainable solutions by supporting the establishment of manufacturing networks on various continents.

“Our first step has been the establishment of our Regional Headquarters for southeast Asia in Singapore which will also include mRNA manufacturing capacities for regional and global supply.

“It is our goal to leverage our proprietary mRNA technology to help improve the health of people around the world.”